ClinicalTrials.gg

Grifols clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 108 studies whose lead sponsor is Grifols or one of 8 companies grouped under it. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 8 registry names, not the registry’s. See them and correct one ↓

Compare Grifols with BeOne Medicines and AstraZeneca →

Pipeline: 5 programs

Each counted once: 5 with a study Grifols leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Grifols’ own registered studies; Grifols’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Grifols’ studies test, most open studies first — 16 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 6 more

Coming up

1 of Grifols’ studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 108 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now87%Recruiting 7 · Enrolling by invitation 1
  • Completed8175%
  • Stopped early1817%Terminated 15 · Withdrawn 3
  • Status unknown or other11%

Phase

  • Phase 254
  • Phase 340
  • Phase 111
  • Phase 49

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 1120
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 326

By the year each study started; 14 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Grifols.

  • Grifols Therapeutics LLC
    Acquired — became part of Grifols, Jun 1, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    46 studies →
  • Instituto Grifols, S.A.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies →
  • Biotest
    Acquired — became part of Grifols, Apr 25, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Alkahest, Inc.
    Acquired — became part of Grifols, Dec 15, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Grifols Biologicals, LLC
    Acquired — became part of Grifols, Jul 2003 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • GigaGen, Inc.
    Acquired — became part of Grifols, Mar 9, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Araclon Biotech S.L.
    Acquired — became part of Grifols, Mar 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Grifols Italia S.p.A
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Grifols leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 108. Browse all 108 →